TIG - TiGenix NV

. Currency in USD
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • The costliest $29 they'll ever win: NJ levies $25K fine
    Associated Press13 days ago

    The costliest $29 they'll ever win: NJ levies $25K fine

    A gambler from Nevada lost $29 on a New Jersey internet gambling site, but the transactions cost a technology company $25,000. New Jersey regulators fined Gaming Innovation Group $25,000 for a flaw in its geolocation technology, which is designed to make sure people are within the state's borders before they can gamble. The state Division of Gaming Enforcement says the Malta-based company, which provides online gambling for Atlantic City's Hard Rock casino, had a technical vulnerability last summer.

  • AP: Ivanka, Kushner could profit from tax break they pushed
    Associated Press5 months ago

    AP: Ivanka, Kushner could profit from tax break they pushed

    WASHINGTON (AP) — At an Oval Office gathering earlier this year, President Donald Trump began touting his administration's new real estate investment program, which offers massive tax breaks to developers who invest in downtrodden American communities. He then turned to one of the plan's strongest supporters.

  • Correction: Kushners-Opportunity Zones story
    Associated Press5 months ago

    Correction: Kushners-Opportunity Zones story

    In a story Dec. 11 about an Opportunity Zone tax break promoted by Ivanka Trump and Jared Kushner, The Associated Press erroneously reported that the couple jointly own a stake in the real estate investment firm Cadre that is launching a series of Opportunity Zone funds. It clarifies that Kushner's stake of between $25 million and $50 million is in a holding company with an ownership stake in Cadre.

  • Job growth is found to be no cure for a community's poverty
    Associated Press7 months ago

    Job growth is found to be no cure for a community's poverty

    A healthy dose of job growth has long been seen as a likely cure for poverty. When such cities as Atlanta and Charlotte enjoyed a job surge in the 20 years that began in 1990, for example, the job gains mostly bypassed residents — often African-American — who had been born into poverty. "Job growth is not sufficient by itself to create upward mobility," Chetty said.

  • Business Wire11 months ago

    Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid in respect of TiGenix and Commencement of Simplified Squeeze-out and Intention to Delist the ADSs from Nasdaq...

    The number of Securities tendered into the Bid, together with all Securities owned by Takeda and its affiliates, represents or gives access to 96.03% of the voting rights represented or given access to by all of the outstanding Securities on a fully diluted basis. Following settlement of the Securities, Takeda will own 96.08% of the outstanding Ordinary Shares (including Ordinary Shares represented by ADSs) and will have acquired 95.76% of the Ordinary Shares that were the subject of the Bid. Following the squeeze-out, TiGenix will become a wholly owned subsidiary of Takeda and the Ordinary Shares will be automatically delisted from Euronext Brussels.

  • Business Wire11 months ago

    Takeda and TiGenix Announce Results of First Acceptance Period for the Voluntary and Conditional Public Takeover Bid of TiGenix and Commencement of Second Acceptance Period

    Takeda Pharmaceutical Company Limited (4502.T) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG) (“TiGenix”) today announced the results of the first acceptance period of Takeda’s previously announced tender offer (the “Bid”) in cash for all outstanding ordinary shares (“Ordinary Shares”), warrants (“Warrants”) and American Depositary Shares (“ADSs,” and together with the Ordinary Shares and the Warrants, the “Securities”) of TiGenix that are not yet owned by Takeda and its affiliates, which expired as scheduled on May 31, 2018, at 4 p.m. CEST/10 a.m. EDT.

  • Business Wirelast year

    Takeda Announces Information Related to its Pending Voluntary and Conditional Public Takeover Bid for Outstanding Shares and American Depositary Shares of TiGenix

    Takeda Pharmaceutical Company Limited today announced information related to its previously announced and ongoing tender offer in cash for all outstanding ordinary shares , warrants and American Depositary Shares of TiGenix NV that are not yet owned by Takeda and its affiliates, in two separate, but concurrent and related offers in Belgium and in the United States (the “U.S.